determining which patients benefit from more than 5 years of antihormonal therapy--

[Jean]

Hi Becky like you this is my 9th year on AI (Femara)
being Estrogen 90%
highly Her2 positive
OncotypeDX was high also ....so for me it was not requiring brain surgery to continue on Femara past 5 yrs.
My concern is next year....after yr.10

http://www.medicalnewstoday.com/releases/274300.php?tw

From article:

"We are about to start a trial called IBIS-3 of extended therapy with aromatase inhibitors in long-term survivors with ER+ breast cancer with other unfavourable characteristics, and also adding new drugs used in other conditions that show promise in preventing breast cancer recurrence - a bisphosphonate (bone sparing drug) and metformin (diabetes drug). Hopefully, this biomarker work will help to pinpoint more accurately which patients need additional treatment."

I am thinking I woud like to take part in this trial.
I am seeing my onc. early April and will discuss this but I am fairly certain i will hear that "we just don't know"
What are your thoughts Becky?
Hugs dear sister,
Jean